You're capturing patient voices. But are they opening doors with payers?
For Medical Affairs, HEOR, and RWE leaders, the challenge is no longer just listening to patients, but systematically converting their lived experiences into robust, regulatory-ready evidence.
On May 28th, five leaders from across the evidence value chain will share exactly how they're closing this gap. Hear directly from those shaping patient-centric evidence: a patient advocate leveraging data for better outcomes, a clinician integrating patient perspectives across diverse APAC markets, R&D and market access leaders from GSK and MSD navigating HTA requirements, and Ipsos' RWE experts bridging methodology with regulatory reality.
What you'll take away
- A practical framework for aligning patient insights with HTA requirements
- Case-based insights on what's working - and what's failing - in patient-centric evidence generation
- Direct perspectives from patients, clinicians, pharma leaders, and RWE specialists
Event details
All registrants will receive an exclusive post-event Executive Summary featuring the frameworks and case studies discussed.
We welcome a conversation before or after the session. Feel free to reach out directly - we're always happy to discuss how patient-centric approaches can strengthen your evidence strategy.
Warm regards,
